Breaking the silence: a national voice for gynaecological cancers
19 October 2006
© Commonwealth of Australia 2006
ISBN 0 642 71680 3
View the report as a single document - (PDF 1252KB)
View the report as separate downloadable parts:
|
|
Membership of the Committee |
(PDF 108KB) |
|
List of Acronyms |
(PDF 68KB) |
|
Executive Summary |
(PDF 75KB) |
|
Recommendations |
(PDF 96KB) |
|
Chapter 1 - Introduction |
(PDF 178KB) |
Terms of Reference
Conduct of the Inquiry
The Committee’s report
Background to the Inquiry
What are gynaecological cancers?
The types of gynaecological cancers
Risk factors for gynaecological cancers
Prevention of gynaecological cancers
The symptoms of gynaecological cancers
Statistics on gynaecological cancers in Australia
Incidence of gynaecological cancers
Projections for new cases of gynaecological cancers
Deaths from gynaecological cancers
Survival rates for women with gynaecological cancers
Conclusion |
|
Chapter 2 - A stronger voice for gynaecological cancers in Australia |
(PDF 181KB) |
Introduction
A national approach
The need for national coordination
A self-determining national body for gynaecological cancers
Benefits of a NGCC
Support from the Australian Society of Gynaecologic Oncologists
Support from community organisations
Relationship with Cancer Australia
Proposal for a National Women’s Cancer Centre
A NGCC to be modelled on the NBCC
Location of a NGCC
Cost of NGCC
Improve existing arrangements
Expansion of the NBCC’s remit to include gynaecological cancers
The need for a separate identity for gynaecological cancers
The way forward |
|
Chapter 3 - Adequacy of research funding for gynaecological cancers |
(PDF 245KB) |
Introduction
Gynaecological cancer research
Clinical trials
The role of Australia New Zealand Gynaecological Oncology Group
Where is the research money coming from?
Commonwealth funding for gynaecological cancer research
Other Commonwealth research funding
The priority of research funding
Research and the National Breast Cancer Centre’s Ovarian
Cancer Program
Community funding for gynaecological cancer research
Cancer Councils’ funding of gynaecological cancer research
Pharmaceutical company funding for gynaecological cancer research
International funding for gynaecological cancer research
Australian Ovarian Cancer Study
Incentives for research contributions
Adequacy of research funding for gynaecological
Barriers to adequate gynaecological cancer research funding
Duplication and an uncoordinated approach
Lack of academic research positions
Lack of clinical trial funding
The importance of clinical trials
Australia’s experience with gynaecological cancer clinical trials
Participation in clinical trials by Indigenous Australians and people
living in rural, remote and regional communities
Adequacy of funding for clinical trials
Adequacy of NHMRC funding for clinical trials
Link between research funding and intellectual interest
Recommended funding levels for gynaecological cancer research
Future gynaecological cancer research needs
The priority of research
A commitment to ongoing funding
The continued need for collaboration
The need for a national approach
A screening test for ovarian cancer
Understanding the symptoms and causes of gynaecological cancers
Conclusion |
|
Chapter 4 - The adequacy of gynaecological cancer care |
(PDF 340KB) |
Introduction
Gynaecological cancer services
Screening programs
Cervical cancer
What is a Pap test?
Liquid-based cytology
Adequacy of the existing Pap test for cervical cancer screening
Indigenous Australians and the Pap test
Utilising regional and rural nurses to conduct Pap tests
Human papilloma virus (HPV)
HPV and cervical cancer
The difference between HPV DNA testing and the Pap test
The benefits of HPV DNA testing to cervical cancer screening
International advancements and HPV DNA testing
Australia’s experience with HPV DNA testing
Potential benefits of HPV DNA testing for Australian women
HPV vaccines
Benefit of vaccines in Indigenous communities
The ability to screen for ovarian cancer
Treatment services
Multidisciplinary treatment
Adequacy of care and provision of treatment services
Issues that impact on the adequacy of treatment services
State and Commonwealth funding for treatment
Service provision in the private and public health systems
Lack of funding for database management infrastructure and resources
Staff shortages and lack of funding
Extended surgical waiting times
Inability to access Magnetic Resonance Imaging (MRI)
Adequacy of psychosocial treatment and services
Inadequacy of treatment provision to rural and remote areas
Tele-medicine and satellite clinics
Psychosocial service provision to rural and remote areas
The role of regional nurses and specialist nurses
Adequacy of treatment provision to Indigenous Australians
Adequacy of treatment for women from multicultural and linguistically diverse populations
The adequacy of interpreting services
Cultural differences impacting on treatment services
The adequacy of treatment to disadvantaged groups in Australia
Patient assisted travel schemes
Current arrangements
Accessing patient assistance
Other treatment and health support programs
Alternative and Complementary
Menopause
Lymphoedema
Support groups
Support for women during and after treatment
Conclusion |
|
Chapter 5 - Gynaecological cancers education for the Medical Community |
(PDF 209KB) |
Introduction
The importance of education
The medical community
General practitioners
Role
Current education strategies
Is the current level of education appropriate?
The way forward
Nurses
Role
Current education about gynaecological cancers
Is the current level of education appropriate?
The way forward
Allied health professionals
Gynaecologists
Gynaecological oncologists
General issues
Coordination and communication
Workforce shortages
Clinical practice guidelines
Education on emerging issues
Communication skills
Skills enhancement training
The Internet
Roles and responsibilities
Conclusion |
|
Chapter 6 - Gynaecological cancers education for Women and the Community |
(PDF 216KB) |
Introduction
The importance of education
Awareness leads to empowerment
Improving awareness of the sub-specialty of gynaecological oncology
Eliminating the stigma associated with gynaecological cancers
Women and the broader community
Women
Broader community
Current education strategies
Current activities
Commonwealth Department of Health and Ageing
National Breast Cancer Centre’s Ovarian Cancer Program
Cancer Councils
Community Organisations
Success of current activities
Vagueness of symptoms
Disproportionate focus on other cancers
Fragmented approach
Personal experiences needed
Misunderstanding about what Pap smears screen for (ie, only cervical cancer)
Lack of media profile
Strategies for change
Areas of focus
Too much education?
A new, coordinated approach
National Awareness Campaign
Broader education about cancer
Factors to consider
One size does not fit all
Overcome stigma and use terminology correctly
Written information
Online information and e-medicine
Face-to-face contact important
Consideration of population differences
Roles and responsibilities
Conclusion |
|
Chapter 7 - Experience, expertise and representation of gynaecological cancer issues |
(PDF 197KB) |
Introduction
Experience and expertise in gynaecological cancers
Medical community and allied health community
Gynaecological cancer organisations
Professional bodies
Community organisations
The Cancer Councils
National health agencies, bodies and initiatives
Commonwealth Department of Health and Ageing
Cancer Australia
Issues regarding the operation of Cancer Australia
National Breast Cancer Centre
Roles and responsibilities in advising the Commonwealth Government
Policy advisory structures
Australian Health Ministers’ Conference and Australian Health Ministers’ Advisory Council
National Cancer Strategies Group and National Health Priority Action Council
The Australian Screening Advisory Committee
National Cancer Control Initiative
Representation of gynaecological oncology issues
The need for greater representation
Improved coordination and leadership
Conclusion |
|
Appendix 1 - List of Public Submissions and Tabled Documents Authorised for publication by the Committee |
(PDF 130KB) |
|
Appendix 2 - Witnesses who appeared before the Committee at Public Hearings |
(PDF 117KB) |
|
Appendix 3 - NHMRC funding for gynaecological cancer in Australia 2000 - 2006 |
(PDF 121KB) |
|
Appendix 4 - Possible sexuality issues involved with gynaecological cancer surgery |
(PDF 377KB) |
For further information, contact:
Committee Secretary
Senate Standing Committees on Community Affairs
PO Box 6100
Parliament House
Canberra ACT 2600
Australia